 |
Genzyme CEO Henri Termeer resisted pressure from Carl Icahn. |
Icahn sold Genzyme stake when prices rose
Move settles talk about sale, breakup
Billionaire investor Carl Icahn, who has shaken up boardrooms at some of the world's best known corporations, has apparently decided to leave Genzyme Corp. alone for now. (Full article: 402 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
